---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-003153"
form_type: "8-K"
ticker: "NXGL"
cik: "0001468929"
company_name: "NEXGEL, INC."
filed_at: "2025-01-22T23:59:59+00:00"
generated_at: "2026-05-27T19:04:41.442866+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# NEXGEL prelim Q4 rev ~$3M, FY2024 ~$8.6M (+100% YoY); guides FY2025 >$13M, cash flow positive

## Summary
- Preliminary Q4 2024 revenue ~$3.0M; full year ~$8.6M, representing >100% YoY growth for third consecutive year.
- 2025 guidance: at least $13M revenue and positive cash flow from operations during the year.
- Silly George run rate grew from $2M to >$5M post-acquisition (May 2024); new beauty under-eye patch planned.
- Contract manufacturing added two large international customers; one began Q4 revenue, other expected Q1 2025.
- Medagel to launch SilverSeal wound kit and burn pads; Kenkoderm to expand into new indication Q3 2025.

## SEC filing metadata
- accession: 0001493152-25-003153
- form_type: 8-K
- ticker: NXGL
- cik: 0001468929
- company_name: NEXGEL, INC.
- filed_at: 2025-01-22T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468929/000149315225003153/0001493152-25-003153-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468929/000149315225003153/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-003153
- JSON: https://secwatch.observer/filing/0001493152-25-003153.json
- Plain text: https://secwatch.observer/filing/0001493152-25-003153.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.